ArticleHypertension research : official journal of the Japanese Society of Hypertension2016

A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats.

Yui Takeshige et al.PubMed ↗Publisher ↗

No numbers read from the abstract.